Refining prognosis in advanced renal cell carcinoma: international real-world validation of the Meet-URO score in first-line immunotherapy combinations
Sara Elena Rebuzzi, Aruni Ghose, S. Rudman, Balaji Venugopal et autres
BACKGROUND: Effective risk stratification is essential for guiding treatment decisions in patients with metastatic renal cell carcinoma (mRCC). The Meet-URO score is a novel prognostic model that integrates the International Metastatic RCC Database Consortium (IMDC) criteria with neutrophil-to-lymphocyte ratio (NLR) and the …
it, gb, cz, tr, hk, us (code pays fourni par la source)
1 citation
The Oncologist